REAL-TIME GLOBAL RESEARCH
Still Waiting For The Feature
Research evidence excerpt
Still Waiting For The Feature
n new cabinet going 360340
forward) which should fill any content gaps, although we expect 2H26 step-up in ANZ sales 320300
to occur largely from 4Q26. 1Q25 2Q25 3Q25 4Q25 1Q26 JEF2Q26 3Q26VA 4Q26 1Q27 2Q27 3Q27 4Q27
.
Source: Company reports, Visible Alpha, Jefferies estimates
High-end of MSD-HSD% AEBITDA growth in FY26 looks difficult to achieve in our view
unless a strong recovery in social or meaningful pick-up in ANZ ship share. We have limited Exhibit 2 - LNW AEBITDA Growth by Segment
confidence in SciPlay recovery, forecasting FY26 revenue -8% y-y. We do expect LNW could 30%25% 28%
achieve 25-30% ANZ share, although game release timing will see this as a 4Q26/1Q27 event 20%15% 13% 15% 16% 15%
6% 7% 5%in our view. We forecast 4.5% AEBITDA growth in FY26 (prev 5.6%). 10% 7% 8% 3%
0%
2%
-5% -6%
Capital management. LNW repurchased $188m of stock in 2Q26, up sharply from $22m -10% FY25 FY26 FY27 FY28
in 1Q26. We believe clearer guidance on future buybacks is needed to support investor . Gaming SciPlay iGaming
confidence. Our forecasts assume $200m of buybacks in 2H26, resulting in ND/AEBITDA Source: Company reports, Jefferies estimates
falling below 3x in 3Q27, later than management's 1H27 target. In our view, achieving this
target would require either stronger cash conversion than we forecast or a pause in buybacks.
Longer term, we expect LNW to adopt a lower leverage range of ~2–3x.
Reiterate BUY despite gearing and earnings risks. We reiterate BUY, largely on valuation.
LNW screens cheap on a PE basis. However, we acknowledge investors are unlikely to reward
buyback-driven EPS growth; we change from a PER to EV/EBITDA SOTP valuation to capture
SciPlay's lower multiple earnings and group net debt in valuation.
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer